USA 99 , 1179011795 (2002)
This is likely further enhanced by an increase in GLP-1expressing L-cells in the gut mucosa [9, 16, 17], and gut mucosa hyperplasia that increases intestinal glucose disposal after RYGB [16]
GLP-1 (glucagon-like peptide-1) is a hormone that influences insulin secretion, slows gastric emptying, and signals fullness to the brain
However, because GLP-1s can produce rapid weight loss (12 lbs/week), the absolute amount of lean mass lost can be significant
For instance, the multidisciplinary expert consensus available at MDPI provides a comprehensive guide to manage gastrointestinal side effects that patients may encounter
Higher-end stack used for visceral fat reduction